Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- Check5 days agoChange DetectedAdded Contacts/Locations and Study Status in revision v3.4.3. The previous v3.4.2 was superseded.SummaryDifference0.3%

- Check12 days agoChange DetectedAdded Contacts/Locations and Study Status sections on 2026-02-27; deletion on 2026-02-18 removed content.SummaryDifference0.2%

- Check20 days agoChange DetectedNew Contacts/Locations and Study Status entries were added in the 2026-02-18 update, and the 2026-02-09 entry was removed.SummaryDifference0.2%

- Check34 days agoChange DetectedVersion 71 (2026-02-06) added Contacts/Locations and updated Study Status, with Revision: v3.4.2. The funding-notice banner from 2026-01-20 was removed.SummaryDifference0.6%

- Check41 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the record history now lists revision v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check48 days agoChange DetectedThe history page now includes a glossary toggle, color-coded additions and deletions, and updated revision notes to v3.4.0, replacing the previous 'No FEAR Act data' entry and v3.3.4.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.